PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
89.1K / 1.73M (Avg.)
-18.12 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-714.16%
Negative net income growth while 1097.HK stands at 35.01%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-1.49%
Negative yoy D&A while 1097.HK is 159.93%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.72%
Negative yoy working capital usage while 1097.HK is 42.75%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-100.00%
AR is negative yoy while 1097.HK is 100.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
100.00%
Some inventory rise while 1097.HK is negative at -100.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
16.51%
Growth well above 1097.HK's 24.62%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-97.47%
Both negative yoy, with 1097.HK at -99.54%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-25.24%
Negative yoy CFO while 1097.HK is 12.22%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
54.36%
CapEx growth well above 1097.HK's 23.02%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-100.00%
Both yoy lines negative, with 1097.HK at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
100.00%
Purchases growth of 100.00% while 1097.HK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-74.45%
We reduce yoy sales while 1097.HK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
110.43%
We have some outflow growth while 1097.HK is negative at -9.80%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
150.97%
Investing outflow well above 1097.HK's 10.07%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy issuance while 1097.HK is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
100.00%
Buyback growth of 100.00% while 1097.HK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.